SCHEMBL8320164

SCHEMBL8320164

COC(=O)C1Cc2c([nH]c3ccccc23)C(c2ccccc2C)N1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 5/20 0.78
CCKBR P32239 2/20 0.72
KDM4E B2RXH2 5/20 0.69
HSD17B10 Q99714 2/20 0.69
TSHR P16473 2/20 0.69
HTT P42858 1/20 0.69
MEN1 O00255 4/20 0.65
KMT2A Q03164 4/20 0.65
ALDH1A1 P00352 4/20 0.56
CYP2D6 P10635 3/20 0.56
CYP2C19 P33261 2/20 0.56
CYP1A2 P05177 1/20 0.56
GAA P10253 1/20 0.56
MAPT P10636 1/20 0.56
CYP2C9 P11712 1/20 0.56
HPGD P15428 1/20 0.56
ALOX15 P16050 1/20 0.56
MAPK1 P28482 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.53
ALOX12 P18054 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17760585 0.89 CCKBR (0.74) PDE5ACCKBRKDM4EHSD17B10TSHR
SCHEMBL17760612 0.89 CCKBR (0.74) PDE5ACCKBRKDM4EHSD17B10TSHR
SCHEMBL1922309 0.88 PDE5A (0.81) PDE5ACCKBRKDM4EHSD17B10TSHR
SCHEMBL14121801 0.88 PDE5A (1.00) PDE5ACCKBRKDM4EHSD17B10TSHR
SCHEMBL8320305 0.88 PDE5A (1.00) PDE5ACCKBRKDM4EHSD17B10TSHR
SCHEMBL14121773 0.88 PDE5A (1.00) PDE5ACCKBRKDM4EHSD17B10TSHR
SCHEMBL14121637 0.88 PDE5A (1.00) PDE5ACCKBRKDM4EHSD17B10TSHR
SCHEMBL8320595 0.88 PDE5A (0.77) PDE5ACCKBRKDM4EHSD17B10TSHR
SCHEMBL17760644 0.88 PDE5A (0.81) PDE5ACCKBRKDM4EHSD17B10TSHR
SCHEMBL17760544 0.88 PDE5A (0.81) PDE5ACCKBRKDM4EHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004113336-A1 CARBOLINE AND BETACARBOLINE DERIVATIVES FOR USE AS HDAC ENZYME INHIBITORS CHROMA THERAPEUTICS LIMITED (GB) 2004-12-29 WO disclosed